TGFB1 and neoplasm: Therefore, we wanted to, first, confirm that blocking TGFβ using a monoclonal anti‐TGFβ antibody (1D11) would prevent rTGFβ1 inhibition of osteoblast differentiation and, second, that 1D11 would result in a bone anabolic effect in naïve and tumor‐bearing mice.